Porous TiO2 surface formed on nickel-titanium alloy by plasma electrolytic oxidation: A prospective polymer-free reservoir for drug eluting stent applications

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 101 B, Issue 5, 2013, Pages 700-708

  Huan, Zhiguang ^a   Fratila Apachitei, Lidy E ^a   Apachitei, Iulian ^a   Duszczyk, Jurek ^a  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

drug eluting stent; nickel titanium alloy; plasma electrolytic oxidation; surface porosity; titanium oxide layer

Indexed keywords

DRUG-ELUTING STENTS; NICKEL TITANIUM ALLOY; PLASMA ELECTROLYTIC OXIDATION; SURFACE POROSITY; TITANIUM OXIDE LAYER;

BIOMEDICAL EQUIPMENT; ELECTROLYSIS; NICKEL ALLOYS; OXIDATION; PLASMAS; POLYMERS; SUBSTRATES; SURFACE ROUGHNESS; TITANIUM ALLOYS; TITANIUM OXIDES; POROSITY;

STENTS;

DRUG CARRIER; ELECTROLYTE; NITINOL; PHOSPHORIC ACID; TITANIUM DIOXIDE; ALLOY; BIOMATERIAL; NICKEL; TITANIUM; TITANIUM NICKELIDE;

ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; LOW TEMPERATURE; MEDICAL DEVICE; OXIDATION; POROSITY; PROSPECTIVE STUDY; RESERVOIR; WETTABILITY; CHEMISTRY; ELECTROLYSIS; MATERIALS TESTING; OXIDATION REDUCTION REACTION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; CHEMICAL COMPOSITION; CONDUCTANCE; ELECTRIC RESISTANCE; POLARIZATION;

ALLOYS; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; DRUG-ELUTING STENTS; ELECTROLYSIS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; NICKEL; OXIDATION-REDUCTION; POROSITY; SURFACE PROPERTIES; TITANIUM; WETTABILITY;

EID: 84878849240     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32872     Document Type: Article

References (41)

1. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL,. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006; 151: 1260-1264.
2. Doyle B, Rihai CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr,. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007; 116: 2391-2398.
3. Stone GW, Moses JW, Ellis SG, Schofer J., Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB,. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
4. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P,. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
5. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW,. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
6. Wessely R, Kastrati A, Schömig A,. Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent subsequently. Ann Intern Med 2005; 143: 392-394.
7. Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, Wintermantel E, Schömig A,. Prevention of restenosis by novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site sent coating. Eur Heart J 2005; 26: 1475-1481.
8. Abizaid A, Costa JR Jr,. New drug-eluting stents: An overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv 2010; 3: 384-393.
9. Hossainy S, Prabhu S,. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating. J Biomed Mater Res A 2008; 87: 487-493.
10. Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Mattos LA, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE,. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of de novo coronary lesions: a first-in-human analysis of a third-generation drug-eluting stent system. JACC Cardiovasc Interv 2008; 1: 545-551.
11. Zhang F, Zheng Z, Chen Y, Liu X, Chen A, Jiang Z,. In vivo investigation of blood compatibility of titanium oxide films. J Biomed Mater Res 1998; 42: 128-133.
12. Williams DF,. Titanium and titanium alloys. In:, Williams DF, editor. Biocompatibility of Clinical Implant Materials, Vol. 1. Boca Raton, Florida: CRC Press; 1981, pp 9-44.
13. Song S, Park YJ, Cho MD, Kim JH, Jeong MH, Kim YS, Cho DL,. Preparation of a drug-eluting stent using a TiO2 film deposited by plasma enhanced chemical vapor deposition as a drug-combining matrix. J Mater Chem 2010; 20: 4792-4801.
14. Windecker S, Mayer I, De Pasquale G, Maier W, Dirsch O, De Groot P, Wu Y, Noll G, Leskosek B, Meier B, Hess OM,. Stent coating with titanium-nitride- oxide for reduction of neointimal hyperplasia. Circulation 2001; 104: 928-933.
15. Frauchiger VM, Schlottig F, Gasser B, Textor M,. Anodic plasma-chemical treatment of CP titanium surfaces for biomedical applications. Biomaterials 2004; 25: 593-606.
16. Yerokhin AL, Nie X, Leyland A, Matthews A, Dowey SJ, Plasma electrolysis for surface engineering. Surf Coat Technol 1999; 122: 73-93.
17. Apachitei I, Lonyuk B, Fratila-Apachitei LE, Zhou J, Duszczyk J,. Fatigue response of porous coated titanium biomedical alloys. Scr Mater 2009; 61: 113-116.
18. 2-Ag antibacterial coatings on Ti6Al7Nb biomedical alloy. Acta Biomater 2011; 7: 2751-2757.
19. Wang HR, Liu F, Zhang YP, Yu DZ, Wang FP,. Preparation and properties of titanium oxide film on NiTi alloy by micro-arc oxidation. Appl Surf Sci 2011; 257: 5576-5580.
20. Chrzanowski W, Abou Neel EA, Armitage DA, Knowles JC,. Surface preparation of bioactive Ni-Ti alloy using alkali, thermal treatments and spark oxidation. J Mater Sci Mater Med 2008; 19: 1553-1557.
21. Matykina E, Berkani A, Skeldon P, Thompson GE,. Real-time imaging of coating growth during plasma electrolytic oxidation of titanium. Electrochimica Acta 2007; 53: 1987-1994.
22. 5 fims. Electrochim Acta 1987; 32: 171-174.
23. Zhang Y, Yan C, Wang F, Lou H, Cao C,. Study on the environmentally friendly anodizing of AZ91D magnesium alloy. Surf Coat Technol 2002; 161: 36-43.
24. Ryu HS, Mun SJ, Lim TS, Kim HC, Shin KS, Hong SH,. Microstructure evolution during plasma electrolytic oxidation and its effects on the electrochemical properties of AZ91D Mg alloy. J Electrochem Soc 2011; 158: C266-C273.
25. Wang Y, Lei T, Jiang B, Guo L,. Growth, microstructure and mechanical properties of microarc oxidation coatings on titanium alloy in phosphate-containing solution. Appl Surf Sci 2004; 233: 258-267.
26. Shabalovskaya S, Anderegg J, Van Humbeeck J,. Critical overview of Nitinol surfaces and their modifications for medical applications. Acta Biomater 2008; 4: 447-467.
27. Matykina E, Monfort F, Berkani A, Skeldon P, Thompson GE, Gough J,. Characterization of spark-anodized titanium for biomedical applications. J Electrochem Soc 2007; 154: C279-C285.
28. Bernard SA, Balla VK, Davies NM, Bose S, Bandyopadhyay A,. Bone cell-materials interactions and ion release of anodized equiatomic NiTi alloy, Acta Biomater 2011; 7: 1902-1912.
29. Chrzanowski W, Abou Neel EA, Armitage DA, Knowles JC,. Surface preparation of bioactive Ni-Ti alloy using alkaline, thermal treatments and spark oxidation. J Mater Sci Mater Med 2008; 19: 1553-1557.
30. Parfenov EV, Yerokhin AL, Matthews A,. Frequency response studies for the plasma electrolytic oxidation process. Surf Coat Technol 2007; 201: 8661-8670.
31. Sundararajan G, Krishna LR,. Mechanisms underlying the formation of thick alumina coatings through the MAO coating technology. Surf Coat Technol 2003; 167: 269-277.
32. Servidori M, Ferrero C, Lequien S, Milita S, Parisini A, Romestain R, Sama S, Setzu S, Thiaudière D,. Influence of the electrolyte viscosity on the structural features of porous silicon. Solid State Commun 2001; 118: 85-90.
33. Yang Y, Wu H,. Effect of current density on corrosion resistance of micro-arc oxide coatings on magnesium alloy. Trans Nonferrous Met Soc China 2010; 20: s688-s692.
34. Hecker JF, Edwards RO,. Effect of roughness on the thrombogenicity of a plastic. J Biomed Mater Res 1981; 15: 1-7.
35. McLucas E, Moran MT, Rochev Y, Carroll WM, Smith TJ,. An investigation into the effect of surface roughness of stainless steel on human umbilical vein endothelial cell gene expression. Endothelium 2006; 13: 35-41.
36. Huang P, Wang F, Xu K, Han Y,. Mechanical properties of titania prepared by plasma electrolytic oxidation at different voltages. Surf Coat Technol 2007; 201: 5168-5171.
37. Annarelli CC, Fornazero J, Cohen R, Bert J, Besse JL,. Colloidal protein solutions as a new standard sensor for adhesive wettability measurements. J Colloid Interface 1999; 213: 386-394.
38. Chrzanowski W, Abou Neel EA, Armitage DA, Knowles JC,. Effect of surface treatment on the bioactivity of nickel-titanium. Acta Biomater 2008; 4: 1969-1984.
39. Wang GX, Shen Y, Zhang H, Quan XJ, Yu QS,. Influence of surface microroughness by plasma deposition and chemical erosion followed by TiO2 coating upon anticoagulation, hydrophilicity, and corrosion resistance of NiTi alloy stent. J Biomed Mater Res Part A 2008; 85A: 1096-1102.
40. Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH,. Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res Part A 2006; 76A: 835-841.
41. Kawatika J, Stratmann M, Hassel AW,. High voltage pulse anodization of a NiTi shape memory alloy. J Electrochem Soc 2007; 154: C294-C298.